ISOP
92 FOLLOWERS
The International Society of Pharmacovigilance (ISoP) is a professional, independent, non-profit society, open to anyone with an interest in the safe and effective use of medicinal products. We provide an open and impartial forum for sharing experience and knowledge,
a platform for discussion and generation of new research and ideas through our website.
ISOP
3w ago
We are pleased to announce that on 19 April at 10.00 Niklas Norén, chief science officer at the Uppsala Monitoring Center (Sweden), will present a seminar entitled “Artificial intelligence in Pharmacovigilance – value proposition and critical appraisal” at the University of Verona, introduced by Gianluca Trifirò. The seminar will be webcast at https://univr.zoom.us/j/95521455804 . The event is a joint initiative of ISoP European Chapter, ISoP SIG Real World Evidence and Big Data and the Pharmacovigilance, Pharmacoepidemiology and Pharmacoeconomics Working Group of the Italian Society of Pharma ..read more
ISOP
3w ago
Join the ISoP Africa Chapter in Kampala from 22 to 24 July 2024 to collaborate and innovate in pharmacovigilance! Explore thematic areas like data-driven decision-making, risk communication, and regulatory harmonization. Check out the video HERE.
Early Bird Registration is now open!
The post Africa Chapter Meeting: Kampala, Uganda ? 22-24 July 2024 appeared first on ISOP ..read more
ISOP
1M ago
The post Eu2P: Boost your career in Drug Safety! Special Prices for ISoP members appeared first on ISOP ..read more
ISOP
2M ago
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have launched two new public electronic catalogues for real-world data (RWD) sources and studies, aiming to boost transparency, encourage the use of good practices and trust in research based on RWD. As part of this initiative, EMA will host a webinar on the catalogues on 4 March 2024 from 10:00 to 12:00 CET. More information is available HERE.
The post Launch of new HMA-EMA catalogues of real-world data sources and studies appeared first on ISOP ..read more
ISOP
2M ago
20 March 2024, 08:00 UTC
Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study”
Co-authored and presented by Nele Brusselaers from the Karolinska Institutet, Sweden.
PV Journal Club Webinars
The post ISoP Pharmacovigilance Journal Club No 8 Webinar (20 March 2024) appeared first on ISOP ..read more
ISOP
2M ago
Africa
The post ISoP Africa Chapter Meeting (22-24 July, 2024) appeared first on ISOP ..read more
ISOP
2M ago
Topic: Tinnitus after covid-19 vaccination as an example of signals challenging for patients and public health authorities.
Speakers: Gregory Poland, Jim Buttery and Hazel Clothier
Chair: Rebecca Chandler
February 27, 2024
14:00 EST | 20:00 CET | 19:00 UTC
Vaccine Surveillance Group
The post ISoP Vaccine Surveillance Group Webinar (27 February 2024) appeared first on ISOP ..read more
ISOP
2M ago
Exciting news! The recordings from the ISoP 22nd Annual Meeting in Bali are now available for your viewing pleasure. Dive into a wealth of enriching materials by unlocking unlimited access today.
Don’t miss out on this opportunity to expand your knowledge and stay ahead in your field. Get access now for a small fee and elevate your learning experience!
ISoP 2023
The post The recordings from the ISoP 22nd Annual Meeting in Bali are now available. appeared first on ISOP ..read more
ISOP
2M ago
Topic: Tinnitus after covid-19 vaccination as an example of signals challenging for patients and public health authorities.
February 27, 202414:00 EST | 20:00 CET | 19:00 UTC
Webinar for ISoP members. More information HERE.
The post ISoP Vaccine Surveillance Group Webinar (27 February 2024). appeared first on ISOP ..read more
ISOP
4M ago
As part of our commitment to fostering growth, innovation, and sustainability within ISoP, we wanted to inform you about an important update regarding our membership fees. Starting January 2024, there will be an adjustment in our membership fee structure to better align with the evolving needs of our community and to support the ongoing initiatives and advancements within ISoP. We greatly appreciate your continued support and understanding as we strive to enhance your experience and further strengthen our collective impact within the field of pharmacovigilance.
Current membership fees will rem ..read more